Abivax (AAVXF) Goodwill (2021 - 2026)

Abivax has reported Goodwill for 6 years, with the latest figure at $21.6 million in Q1 2026.

• On a quarterly basis, Goodwill rose 11.3% year-over-year to $21.6 million in Q1 2026; TTM through Mar 2026 was $21.6 million, a 11.3% increase from a year earlier, with the FY2025 full-year figure at $21.4 million, up 8.93% from the prior year.
• Goodwill was $21.6 million for Q1 2026 at Abivax, up from $21.4 million in the prior quarter.
• The five-year high for Goodwill was $21.6 million in Q1 2026, with the low at $18.8 million in Q4 2022.
• Average Goodwill over 5 years is $20.3 million, with a median of $19.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Goodwill slumped 48.67% in 2022, then advanced 11.3% in 2026.
• Over 5 years, Goodwill stood at $18.8 million in 2022, then gained by 5.46% to $19.8 million in 2023, then declined by 0.68% to $19.7 million in 2024, then gained by 8.93% to $21.4 million in 2025, then grew by 0.58% to $21.6 million in 2026.
• The last three Goodwill figures came in at $21.6 million (Q1 2026), $21.4 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.